. Author manuscript; available in PMC: 2014 Dec 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2013 Sep 30;19(12):1725–1730. doi: 10.1016/j.bbmt.2013.09.015

Table 3.

Multivariable analysis of short and long-term outcomes for all patients according to UCBT platform

Outcome	Relative Risk (95% CI)		P

	Valencia platform	Minneapolis platform
Myeloid engraftment	1	0.6 (0.449 – 0.802)	0.0006
Platelet engraftment	1	0.59 (0.43 – 0.83)	0.002
Acute GvHD, grade II–IV	1	2.81 (1.75 – 4.35)	< 0.0001
Chronic GvHD	1	0.7 (0.31 – 1.60)	0.4
Transplant-related mortality	1	1.06 (0.66 – 1.71)	0.8
Relapse	1	0.52 (0.25 – 1.08)	0.08
Leukemia-free survival	1	1,27 (0.86 – 1.88)	0.23